Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

1,277 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,277 results

Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Post-approval studies (Phase 4)Study completedNCT00108238
What this trial is testing

Estrogen Alternatives Study

Who this might be right for
Healthy
US Department of Veterans Affairs
Testing effectiveness (Phase 2)Active Not RecruitingNCT03740204
What this trial is testing

The Role of Estrogen in the Neurobiology of Eating Disorders

Who this might be right for
Eating DisordersHypoestrogenemia
Massachusetts General Hospital 120
Not applicableStudy completedNCT00572858
What this trial is testing

Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women

Who this might be right for
Estrogen Deficiency
Cedars-Sinai Medical Center 75
Not applicableStudy completedNCT02218463
What this trial is testing

Treatment of Prepubertal Labial Adhesions

Who this might be right for
Prepubertal Labial Adhesions
Children's Mercy Hospital Kansas City 43
Post-approval studies (Phase 4)UnknownNCT02264743
What this trial is testing

Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

Who this might be right for
Venous ThrombosisInsulin Resistance
Royal Brompton & Harefield NHS Foundation Trust 60
Testing effectiveness (Phase 2)Study completedNCT02187991
What this trial is testing

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+1 more
US Oncology Research 169
Testing effectiveness (Phase 2)UnknownNCT03168074
What this trial is testing

Phase II Study of Single Agent Lenvatinib

Who this might be right for
Breast Cancer
National University Hospital, Singapore 30
Large-scale testing (Phase 3)Study completedNCT00745108
What this trial is testing

Tibolone Endometrium Study (Study 32972)(P06470)

Who this might be right for
Postmenopausal Women
Organon and Co 32
Not applicableStudy completedNCT01381016
What this trial is testing

Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

Who this might be right for
ObesityInfertility
University of Colorado, Denver 30
Testing effectiveness (Phase 2)Ended earlyNCT04059484
What this trial is testing

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 367
Testing effectiveness (Phase 2)Study completedNCT02197897
What this trial is testing

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

Who this might be right for
Bladder Cancer
Baylor College of Medicine 15
Post-approval studies (Phase 4)WithdrawnNCT03724955
What this trial is testing

Pilot E2 for Hypogonadal Women With CFBD

Who this might be right for
Cystic Fibrosis Related Bone Disease
Emory University
Large-scale testing (Phase 3)Active Not RecruitingNCT04975308
What this trial is testing

Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 874
Not applicableWithdrawnNCT06978478
What this trial is testing

An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6

Who this might be right for
Breast Cancer
Queen Mary University of London
Large-scale testing (Phase 3)Study completedNCT00066690
What this trial is testing

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more
ETOP IBCSG Partners Foundation 3,066
Testing effectiveness (Phase 2)WithdrawnNCT03644589
What this trial is testing

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more
University of Washington
Testing effectiveness (Phase 2)Study completedNCT00082810
What this trial is testing

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 33
Post-approval studies (Phase 4)Ended earlyNCT05428215
What this trial is testing

Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

Who this might be right for
Gender Dysphoria
MaineHealth 2
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Next Page